sarsiaseed.com

Sarsiaseed | - seed capital

ScreenCancer starter føflekkscanning i England. Avexxin med «proof-of-concept» for ny psoriasisbehandling. Martin Bonde ny CEO i Vaccibody. BerGenBio starter ny klinisk studie med kreftpasienter. ScreenCancer utvider i Sverige. Prestisjefylt designpris til Volusense Pediatrics. Vaccibody klar til å starte kliniske forsøk i menneske. Vaccibody får viktig patent innvilget i USA. BerGen Bio henter NOK 90 mill. Vår styrke er teamets dype sektorforståelse, samt den erfaring. Og det nettverk teamet har tilgang.

http://www.sarsiaseed.com/

OVERVIEW OF sarsiaseed.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

14

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR SARSIASEED.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

September

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 12 reviews

5 star

1

4 star

6

3 star

4

2 star

0

1 star

1

Hey there! Start your review of sarsiaseed.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

3.3 seconds

CONTACTS AT SARSIASEED.COM

Sarsia Innovation

Øivind Enger

Thormø●●●●●●ens gate 55

Be●●en , N-5008

NO

47 6●●●●6570

ho●●●●●●●●@telecomputing.no

View this contact

TeleComputing Norway AS

Frode Omdal Arnesen

P. O●●●●ox 7

As●●er , 1371

NO

47.9●●●●6570

47.6●●●●6571

ho●●●●●●●●@telecomputing.no

View this contact

TeleComputing Norway AS

Frode Omdal Arnesen

P. O●●●●ox 7

As●●er , 1371

NO

47.9●●●●6570

47.6●●●●6571

ho●●●●●●●●@telecomputing.no

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2006 August 28
UPDATED: 2013 February 12
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

17

YEARS
9

MONTHS
9

DAYS

NAME SERVERS

1: ns1.telecomputing.no
2: ns2.telecomputing.no

REGISTRAR

DOMAININFO AB D/B/A DOMAININFO.COM

WHOIS : whois.domaininfo.com

REFERRED : http://www.domaininfo.com

CONTENT

PAGES IN
THIS WEBSITE

14

SSL

EXTERNAL LINKS

7

SITE IP

194.63.248.35

LOAD TIME

3.336 sec

SCORE

6.2

PAGE TITLE

Sarsiaseed | - seed capital | sarsiaseed.com Reviews

<META> DESCRIPTION

ScreenCancer starter føflekkscanning i England. Avexxin med «proof-of-concept» for ny psoriasisbehandling. Martin Bonde ny CEO i Vaccibody. BerGenBio starter ny klinisk studie med kreftpasienter. ScreenCancer utvider i Sverige. Prestisjefylt designpris til Volusense Pediatrics. Vaccibody klar til å starte kliniske forsøk i menneske. Vaccibody får viktig patent innvilget i USA. BerGen Bio henter NOK 90 mill. Vår styrke er teamets dype sektorforståelse, samt den erfaring. Og det nettverk teamet har tilgang.

<META> KEYWORDS

1 hjem

2 om sarsia seed

3 strategi

4 portefølje

5 nyheter

6 kontakt

7 såkornkapital

8 life science

9 energi/cleantech

10 vaccibody i media

CONTENT

Page content here

KEYWORDS ON PAGE

hjem,om sarsia seed,strategi,portefølje,nyheter,kontakt,såkornkapital,life science,energi/cleantech,vaccibody i media,se flere nyheter,fondet,styrke,internasjonal,sarsia presentasjon,presentasjon,sider,co investorer,sarsia team,sveinung hole,øivind enger

SERVER

Apache/2.2.16

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Sarsiaseed | - seed capital | sarsiaseed.com Reviews

https://sarsiaseed.com

ScreenCancer starter føflekkscanning i England. Avexxin med «proof-of-concept» for ny psoriasisbehandling. Martin Bonde ny CEO i Vaccibody. BerGenBio starter ny klinisk studie med kreftpasienter. ScreenCancer utvider i Sverige. Prestisjefylt designpris til Volusense Pediatrics. Vaccibody klar til å starte kliniske forsøk i menneske. Vaccibody får viktig patent innvilget i USA. BerGen Bio henter NOK 90 mill. Vår styrke er teamets dype sektorforståelse, samt den erfaring. Og det nettverk teamet har tilgang.

INTERNAL PAGES

sarsiaseed.com

1

Vaccibody klar til å starte kliniske forsøk i menneske (10.03.15) | Sarsiaseed

http://www.sarsiaseed.com/vaccibody-klare-til-a-starte-kliniske-forsok-i-menneske-10-03-15

Vaccibody klar til å starte kliniske forsøk i menneske. Vaccibody klar til å starte kliniske forsøk i menneske. Vaccibody har annonsert at de har innlevert en såkalt «Clinical Trial Application» hos tyske legemiddemyndigheter. I sin søknad til legemiddelmyndighetene ber Vaccibody om tillatelse til å starte kliniske forsøk med vaksinekandidaten VB10.16 som er en terapøytisk vaksinekandidat for behandling av forstadier til livmorhalskreft. Vaccibody planlegger å utføre studien ved f...47 90 93 28 72.

2

Vaccibody får viktig patent innvilget i USA (16.02.15) | Sarsiaseed

http://www.sarsiaseed.com/vaccibody-far-viktig-patent-godkjent-i-usa-16-02-15

Vaccibody får viktig patent innvilget i USA. Vaccibody får viktig patent innvilget i USA. Amerikanske patentmyndigheter (USPTO) har nettopp innvilget en patentsøknad fra Vaccibody . Det nye patentet gir selskapet beskyttelse for sentrale deler av selskapets teknologiplattform. Selskapet fikk i desember 2014 et tilsvarende patent innvilget av europeisake patentmyndigheter. Les mer. 47 90 93 28 72. 47 95 27 28 39. 47 90 06 23 03. 47 90 59 72 90. 47 95 23 76 49. Marineholmen, 2 etasje. Fax: 47 5559 5948.

3

BerGen Bio henter NOK 90 mill (16.12.14) | Sarsiaseed

http://www.sarsiaseed.com/bergen-bio-henter-nok-90-mill-16-12-14

BerGen Bio henter NOK 90 mill. BerGen Bio henter NOK 90 mill. BerGen Bio har nettopp hentet inn NOK 90 mill gjennom en emisjon rettet mot eksisterende og nye investorer. Pengene skal brukes til videre klinisk utvikling av selskapets legemiddelkandidat BGB342 som for tiden er under klinisk utprøving i pasienter med kreftformen akutt myelogen leukemi (AML). Selskapet vil innen kort tid igangsette en klinisk studier også i pasienter med lungekreft av typen «non-small-cell». Les mer. 47 90 93 28 72.

4

Om Sarsia Seed | Sarsiaseed

http://www.sarsiaseed.com/meet-our-team

Sarsia Seed Management er et bredt sammensatt team med lang erfaring innen fondets investeringsområder og tilstøtende områder. Teamet, med sitt styre og det samlede miljøet på Marineholmen, har et omfattende faglig, industrielt, akademisk og finansnettverk både i Norge, norden og internasjonalt. Etter behov setter teamet sammen og arrangerer spisskompetente workshops eller evalueringsgrupper for å ta stilling til aktuelle faglige eller kommersielle spørsmål. Erlend Skagseth, Managing Partner (MBA). Prekl...

5

ScreenCancer utvider i Sverige (22.05.15) | Sarsiaseed

http://www.sarsiaseed.com/screencancer-utvider-i-sverige-22-05-15

ScreenCancer utvider i Sverige. ScreenCancer utvider i Sverige. ScreenCancer har, i samarbeid med den svanske apotekkjeden Hjärtati, det siste halve året hatt et pilotprosjekt med føflekscanning i 10 apotek i Sverige. Prøveprosjektet har vært en utbetinget suksess og nå utvides aktiviteten i Sverige til totalt 30 apotek – fortsatt i samarbeid med apotekkjeden Hjärtat. Les mer. 47 90 93 28 72. 47 95 27 28 39. 47 90 06 23 03. 47 90 59 72 90. 47 95 23 76 49. Marineholmen, 2 etasje. Fax: 47 5559 5948.

UPGRADE TO PREMIUM TO VIEW 9 MORE

TOTAL PAGES IN THIS WEBSITE

14

LINKS TO THIS WEBSITE

apim-therapeutics.com

APIM Therapeutics | Disabling Cancer's Ability to Escape Treatment

http://www.apim-therapeutics.com/media_center.html

MEDIA CENTER - 2015 - 2016. May 19, 2016. APIM Therapeutics's CSO and NTNU Professor Marit Otterlei presents efficacy results obtained with ATX-101 in bladder and basal-like breast cancer models at the AACR Precision Medicine Series Conference: Targeting the Vulnerabilities of Cancer (Miami, May 16-19, 2016). A copy of the poster presented is available here. May 13, 2016. APIM Therapeutics will be participating at the BIO 2016 International Convention. In San Francisco (June 6-9, 2016). April 11, 2016.

apimtherapeutics.com

APIM Therapeutics | Disabling Cancer's Ability to Escape Treatment

http://www.apimtherapeutics.com/about_us.html

APIM Therapeutics AS is a spin-off from the Norwegian University of Science and Technology (NTNU, Trondheim). Based on an original discovery by Prof. Marit Otterlei and co-inventors, the company targets a novel therapeutic intervention point within the DNA Damage Response Pathway (DDR) allowing the potentiation of the action of 25 clinical drugs across multiple cancer indications. Kostas Alevizopoulos, PhD. Chief Executive Officer. Kostas Alevizopoulos, the CEO of APIM Therapeutics since 2010, is a busin...

apimtherapeutics.com

APIM Therapeutics | Disabling Cancer's Ability to Escape Treatment

http://www.apimtherapeutics.com/media_center.html

MEDIA CENTER - 2015 - 2016. May 19, 2016. APIM Therapeutics's CSO and NTNU Professor Marit Otterlei presents efficacy results obtained with ATX-101 in bladder and basal-like breast cancer models at the AACR Precision Medicine Series Conference: Targeting the Vulnerabilities of Cancer (Miami, May 16-19, 2016). A copy of the poster presented is available here. May 13, 2016. APIM Therapeutics will be participating at the BIO 2016 International Convention. In San Francisco (June 6-9, 2016). April 11, 2016.

apim-therapeutics.com

APIM Therapeutics | Disabling Cancer's Ability to Escape Treatment

http://www.apim-therapeutics.com/about_us.html

APIM Therapeutics AS is a spin-off from the Norwegian University of Science and Technology (NTNU, Trondheim). Based on an original discovery by Prof. Marit Otterlei and co-inventors, the company targets a novel therapeutic intervention point within the DNA Damage Response Pathway (DDR) allowing the potentiation of the action of 25 clinical drugs across multiple cancer indications. Kostas Alevizopoulos, PhD. Chief Executive Officer. Kostas Alevizopoulos, the CEO of APIM Therapeutics since 2010, is a busin...

oslocancercluster.no

Oslo Cancer Cluster | Access to Capital

http://oslocancercluster.no/portfolio-item/access-to-capital

A Dedicated Oncology Cluster. Norwegian Centres of Expertise. Talent & Education. National Cancer Drug Fund. Oslo Cancer Cluster has since 2009 worked to improve our members access to capital, both on the public and private side. Funding is crucial for researchers, start-ups and SME`s as it. Takes a long time and also a lot of funding to develop a cancer medication from bench to bedside. Radium Hospital Research Foundation. The Norwegian Cancer Society. Research Council of Norway. Oslo Cancer Cluster has...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

7

OTHER SITES

sarsi.ru

Информационные сайты Саратова

Реклама на саратовских сайтах. Реклама в социальных сетях. Как создать анимированный баннер. Добавление баннера к форуму или социальной странице может связать основной сайт с заинтересованными людьми. Те, кто не очень разбирается в технологиях, может воспользоваться несколькими простыми инструментами, как создать анимированный баннер: немного практики и готово. Как только баннер будет создан, можно разместить его на бесплатных сайтах, захватив HTML-код и отправив его по всему Интернету. Реклама в блогах ...

sarsi1210.skyrock.com

Blog de sarsi1210 - Marica aka Sarah - Skyrock.com

Mot de passe :. J'ai oublié mon mot de passe. La FoLIe EsT La sAgEsSE réUnIe DaNs Le MeMe HoMme! Mise à jour :. Abonne-toi à mon blog! Les droles de dames 8-p. Les droles de dames 8-p. N'oublie pas que les propos injurieux, racistes, etc. sont interdits par les conditions générales d'utilisation de Skyrock et que tu peux être identifié par ton adresse internet (23.21.86.101) si quelqu'un porte plainte. Ou poster avec :. Posté le mercredi 17 février 2010 14:15. Modifié le mercredi 17 février 2010 14:35.

sarsia.com

Sarsia

Invest in research-based commercialisation initiatives in the Nordic region. We invest in start-up companies in the energy /clean technology sector as well as the biotechnology/ life science sectors. Tel : 47 5559 5949. Fax : 47 5559 5948. 5006 Bergen, Norway. Sarsia Seed AS is a Norwegian. Seed capital fund which invests in Norwegian early phase. Technology companies within the energy/ cleantech and biotechnology/life science sectors. Sarsia Seed actively seeks.

sarsia.livejournal.com

sarsia

Анонс мастер-класса в Москве. 2 г 10 мес. 2 г 11 мес. 2 г 5 мес. 2 г 6 мес. 2 г 7 мес. 2 г 8 мес. 2 г 9 мес. 3 г 1 мес. 3 г 2 мес. 3 г 4 мес. 3 г 5 мес. 3 г 9 мес. 4 г 8 мес. 4 г 9 мес. 5 л 2 мес. Не поваляешь не поешь. От 5 до 6. От 6 до 7. От 7 до 8. От 8 до 9. Скорблю и буду помнить. Многие знают (или не знают, пока) меня под творческим псевдонимом Ацикулярис. Однажды я увлеклась валянием из шерсти. Мне удалось найти свою индивидуальную нишу и стать популярным. Можно полюбоваться на то, что я натворила.

sarsiad.com

Saray Sanayici İş Adamları Derneği

Yeni Türk Ticaret Kanunu Rehberi. Derneğ imiz 25 Mayıs 2013 günü Saray Sanayici ve İşadamları Derneği olarak kuruldu. Kuruluş amacına. Tüm Üyelerimizi açılışa bekleriz. 24 Ocak 2014 günü saat : 15:00 'de Saray Mahallesi, Kerestecile. Sayın Kazan Kaymakamı Veysel Beyru, Sayın Kazan Belediye Başkan Yardımcısı Orhan Yazıcı, Sayın S. YÖNETİM KURULU BAŞKANIMIZ SAYIN İLYAS DAĞ'IN KERESTECİLER SANAYİ SİTESİ SORUNLARI İLE İLGİLİ YENİ SA. Sayın Kazan Kaymakamı Veysel Beyru,. Sayın Derneğimizin Kurucu Üyeleri,.

sarsiaseed.com

Sarsiaseed | - seed capital

ScreenCancer starter føflekkscanning i England. Avexxin med «proof-of-concept» for ny psoriasisbehandling. Martin Bonde ny CEO i Vaccibody. BerGenBio starter ny klinisk studie med kreftpasienter. ScreenCancer utvider i Sverige. Prestisjefylt designpris til Volusense Pediatrics. Vaccibody klar til å starte kliniske forsøk i menneske. Vaccibody får viktig patent innvilget i USA. BerGen Bio henter NOK 90 mill. Vår styrke er teamets dype sektorforståelse, samt den erfaring. Og det nettverk teamet har tilgang.

sarsiaventure.com

www.sarsiaventure.com

The document is located here.

sarsibytes.blogspot.com

..gothic tearz..

Friday, December 16, 2005. Me in da house again.omg.im so hungry(yeah like forever).but i gota control muh temptations.resist delicious deep fried food as advised by jessie, my personal beautician at jean yip's.Yeah.finallie got the jist of a full facial.a promo thgy at j.yip- lot 1.cheapo trial at 42 inc. of gst.but its realli WORTH d money. Okn Princey saved d day.(heart n kiss wink).n he went offline rite after.haizz.(damn i miss u.DO U NOE DAT? She first recommended me a 1000 plus package wic i canno...

sarsicola.blogspot.com

SARAH

Sarah VS fruit ninja. Disclaimer: i am not doing a review on the product, i am just merely overjoyed about it. I've been eyeing this for months since i moved to a new house last january and trying to live a healthy life. but its too expensive that i've finally let go of the thought and thought of buying a cheaper one to use. Sarah VS muffin top. I think i'll have this in white. i just need a skinny body to go with this. :(. Well at least my shoes still fit. Sarah VS animal cruelty. Sarah VS sticky notes.

sarsidoo.wordpress.com

Protected Blog › Log in

This site is marked private by its owner. If you would like to view it, you’ll need two things:. A WordPress.com account. Don’t have an account? All you need is an email address and password register here! Permission from the site owner. Once you've created an account, log in and revisit this screen to request an invite. If you already have both of these, great! Larr; Back to WordPress.com.

sarsie.com

My web page

Arriving at some point in the future. Thanks for stopping by!